文献速递中医内科中医儿科中药与中成药合理使用

金振口服液抗流感肺损伤的代谢组学与肠道菌群机制

Mechanism of Jinzhen Oral Liquid against influenza-induced lung injury based on metabonomics and gut microbiome.
PubMed 文献 · J Ethnopharmacol · 2022-12-05

该研究以甲型H1N1流感病毒感染小鼠模型探究金振口服液(JZOL)抗流感肺损伤机制。JZOL由八味中药组成,可显著减轻肺部炎症与水肿,并通过调节甘油磷脂与脂肪酸代谢及乳杆菌(Lactobacillus)缓解代谢紊乱与肠道菌群失衡,且其抗流感效应依赖于肠道菌群。

要点

  • 金振口服液可减轻H1N1流感小鼠的肺部炎症与水肿。
  • 其作用与调节甘油磷脂和脂肪酸代谢及乳杆菌丰度相关。
  • 抗生素处理证明金振口服液的抗流感效应依赖肠道菌群。

核心结论

  • 金振口服液通过调节乳杆菌介导的脂质代谢,减轻H1N1流感感染诱导的肺损伤。

研究设计与样本

  • 采用鼻内滴注甲型流感(H1N1)复制小鼠肺损伤模型,评估金振口服液疗效。
  • 通过病理切片、肺指数、TNF-α与IFN-γ水平及肺组织病毒载量评价药效。
  • 采用血浆代谢组学技术与16S rRNA高通量测序评估内源性代谢物与肠道菌群调控。
  • 通过抗生素处理验证金振口服液抗流感效应的肠道菌群依赖性。

主要发现

  • 金振口服液显著缓解流感小鼠肺部炎症与水肿。
  • 金振口服液主要调控甘油磷脂与脂肪酸代谢及乳杆菌,缓解内源性代谢物紊乱与肠道菌群失衡。
  • 抗生素处理证明金振口服液的抗流感效应依赖肠道菌群。
  • 改变的代谢物与乳杆菌及药效指标显著相关,证实结果可靠性。

关键数值与推荐

  • 金振口服液由八味中药组成,比例为9.45 : 47.25 : 94.5 : 31.5 : 15.75 : 31.5 : 15.75 : 23.62。
  • 药效评价指标包括病理切片、肺指数、TNF-α与IFN-γ水平及肺组织病毒载量。
  • 代谢组学与16S rRNA测序用于评估血浆代谢物与肠道菌群变化。
  • 抗生素处理用于验证肠道菌群依赖性。

临床怎么用

  • 金振口服液临床用于多种病毒感染所致肺损伤、肺炎和支气管炎,具有良好抗病毒作用。
  • 本研究为其通过调节肠道菌群与脂质代谢治疗流感肺损伤提供机制依据。

局限性

  • 研究仅基于小鼠模型,尚需临床研究验证。
  • 具体活性成分及直接作用靶点未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Jinzhen Oral Liquid (JZOL) is a traditional Chinese patent medicine and widely used clinically, which consists of eight herbs including Bovis Calculus Atifactus, Fritillariae Ussuriensis Bulbus (Fritillaria ussuriensis Maxim.), Caprae Hircus Cornu, Rhei Radix et Rhizoma (Rheum palmatum L.), Scutellariae Radix (Scutellaria baicalensis Georgi), Glycyrrhizae Radix et Rhizoma (Glycyrrhiza uralensis Fisch. ex DC.), Chloriti Lapis, and Gypsum Fibrosum (Their ratio is 9.45 : 47.25: 94.5 : 31.5: 15.75 : 31.5: 15.75 : 23.62). A large number of clinical studies have proved that JZOL has a good antiviral effect and can treat lung injury, pneumonia, and bronchitis caused by a variety of viral infections. AIM OF THE STUDY: Influenza infection frequently exhibit dysregulation of gut microbiota and host metabolomes, but the mechanism of JZOL is still unclear and needs to be further explored. Here, after influenza virus infection induced lung injury, the regulation roles of JZOL in metabolic and gut microbiota balances are investigated to comprehensively elucidate its therapeutic mechanism. MATERIALS AND METHODS: A mouse model of lung injury was replicated via intranasal instillation of influenza A (H1N1). The efficacy of JZOL was evaluated by pathological sections, lung index, the levels of TNF-α and IFN-γ, and viral load in lung tissue. Its modulation of endogenous metabolites and gut microbiota was assessed using plasma metabolomic technique and 16S rRNA high-throughput sequencing technique. RESULTS: JZOL not only significantly relieved lung inflammation and edema in influenza mice, but also alleviated the disturbance of endogenous metabolites and the imbalance of gut microbiota mainly by regulating glycerophospholipid and fatty acid metabolism and Lactobacillus. The anti-influenza effects of JZOL were gut microbiota dependent, as demonstrated by antibiotic treatment. The altered metabolites were significantly correlated with Lactobacillus and pharmacodynamic indicators, further confirming the reliability of these results. CONCLUSIONS: JZOL attenuates H1N1 influenza infection induced lung injury by regulating lipid metabolism via the modulation of Lactobacillus. The results support the clinical application of JZOL, and are useful to further understand the mechanism of TCM in the treatment of influenza.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Feng J, Gao X, Chen X, et al. Mechanism of Jinzhen Oral Liquid against influenza-induced lung injury based on metabonomics and gut microbiome. J Ethnopharmacol. 2022. PMID: 36481245. doi:10.1016/j.jep.2022.115977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。